( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
147555.2
140512.2
122100.5
115420
Total Expenditure
124853
119288.6
103962.1
96223
PBIDT (Excl OI)
22702.2
21223.6
18138.4
19197
Other Income
-103
-140
396.6
-681.6
Operating Profit
22599.2
21083.6
18535
18515.4
Interest
5610.5
5523.9
5505.6
5508
Exceptional Items
-500.8
NA
NA
NA
PBDT
16487.9
15559.7
13029.4
13007.4
Depreciation
3228.5
3204.2
3148.3
2918
Profit Before Tax
13259.4
12355.5
9881.1
10089.4
Tax
4318.7
3905.3
3343.3
3061.8
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
8940.70
8450.20
6537.8
7027.59
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
8940.70
8450.20
6537.8
7135.69
Minority Interest
-499.7
-372.8
-328.2
-493.5
Shares of Associates
-28.1
-122.6
-109.2
-160.6
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
8412.9
7954.8
6100.4
6481.6
Equity Capital
475.1
475.1
475.1
475.1
Calculated EPS
17.70
16.74
12.84
13.64
Calculated EPS (Annualised)
70.83
66.97
51.36
54.57
No of Public Share Holdings
236274328
236274328
236274328
236274328
% of Public Share Holdings
49.73
49.74
49.73
49.73
PBIDTM% (Excl OI)
15.38
15.10
14.85
16.63
PBIDTM%
15.31
15.00
15.18
16.04
PBDTM%
11.17
11.07
10.67
11.26